Cytosorbents

$8.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+1.01%) Today

$0.00 (0.00%) As of 9:14 PM UTC after-hours

Why Robinhood?

You can buy or sell Cytosorbents and other stocks, options, and ETFs commission-free!

About CTSO

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO

Phillip P. Chan

Employees

195

Headquarters

Monmouth Junction, New Jersey

Founded

2002

Market Cap

383.70M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

198.61K

High Today

$9.01

Low Today

$8.80

Open Price

$9.00

Volume

114.01K

52 Week High

$11.74

52 Week Low

$7.13

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

CTSO Earnings

-$0.22

-$0.15

-$0.07

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 4, After Hours